Epilepsy Trial, Recruiting NCT07460037 Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University Condition: Epilepsy
Back to Epilepsy

Epilepsy Trial, Recruiting

NCT07460037
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged between 20 and 80 years old
  • People who are willing and able to understand and agree to the study procedures
  • People who do not have severe emotional or consciousness problems before the procedure that would prevent them from taking part in study tasks
  • (For the temporary brain monitoring group) People who have a brain tumour in or near important brain areas, or difficult-to-control epilepsy, and are already scheduled for an awake brain surgery as part of their standard care
  • (For the temporary brain monitoring group) People whose tumour or affected area involves or is close to parts of the brain that control language, movement, or memory
  • (For the temporary brain monitoring group) People who do not have severe pressure building up inside the skull
  • (For the temporary brain monitoring group) People whose language abilities before surgery are mostly intact — with naming, reading, and understanding at or above 80% of normal levels
  • (For the permanent implant group) People who have severe difficulty speaking or using language due to stroke, brain tumour, ALS (motor neurone disease), or locked-in syndrome
  • (For the permanent implant group) People whose condition has not improved substantially after 3 to 6 months of proper rehabilitation, and whose condition has lasted more than 12 months
  • (For the permanent implant group) People whose brain areas involved in imagining or planning speech are still structurally intact (confirm with trial site)
  • (For the permanent implant group) People diagnosed with severe difficulty producing speech or severe difficulties with language, with a very low score on a standardised Chinese language test, but whose ability to understand spoken language remains at or above 80% of normal levels

Who may not be able to join:

  • People with severe pressure inside the skull that would make awake brain surgery or electrode placement unsafe
  • People with severe brain or nervous system problems that would stop them from taking part in study procedures (note: this does not apply to speech or language difficulties in the permanent implant group)
  • People who cannot have an MRI scan, or who cannot undergo awake brain surgery — for example due to certain implanted medical devices, severe claustrophobia, or a breathing condition called obstructive sleep apnea
  • People with severe psychiatric illness or significant memory and thinking difficulties (based on a standard cognitive test score below 24)
  • People with serious health conditions affecting other parts of the body
  • People who are pregnant or breastfeeding
  • People who are unwilling or unable to give informed consent

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Feng Yan, Department of Neurosurgery, Second Affiliated Hospital, School of Medicine, Zhejiang University

Phone: +86 19032580606

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
15 March 2026
Est. completion
31 December 2028

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Electrode Signal Quality Assessment; Decoding Classification Accuracy

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov